Marshall Wace
VYGR icon

Marshall Wace’s Voyager Therapeutics VYGR Stock Holding History

Marshall Wace’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$488K Buy
+139,422
New +$529K ﹤0.01% 2537
2024
Q2 		– Sell
-47,808
Closed -$445K – 3003
2024
Q1 		$445K Sell
47,808
-26,935
-36% -$227K ﹤0.01% 1978
2023
Q4 		$631K Sell
74,743
-133,819
-64% -$971K ﹤0.01% 1633
2023
Q3 		$1.62M Sell
208,562
-260,715
-56% -$2.38M ﹤0.01% 1320
2023
Q2 		$5.37M Buy
469,277
+402,280
+600% +$4.16M 0.01% 989
2023
Q1 		$517K Buy
+66,997
New +$533K ﹤0.01% 2086
2022
Q4 		– Sell
-189,736
Closed -$1.12M – 3461
2022
Q3 		$1.12M Buy
+189,736
New +$1.21M ﹤0.01% 2352
2022
Q2 		– Sell
-305,445
Closed -$2.33M – 3897
2022
Q1 		$2.33M Sell
305,445
-136,436
-31% -$609K ﹤0.01% 1959
2021
Q4 		$1.2M Buy
+441,881
New +$1.51M ﹤0.01% 2386
2021
Q3 		– Sell
-21,852
Closed -$90K – 3472
2021
Q2 		$90K Sell
21,852
-10,843
-33% -$49.1K ﹤0.01% 2541
2021
Q1 		$154K Buy
+32,695
New +$223K ﹤0.01% 2313
2020
Q3 		– Sell
-95,954
Closed -$1.21M – 1954
2020
Q2 		$1.21M Sell
95,954
-98,490
-51% -$1.15M 0.01% 943
2020
Q1 		$1.78M Buy
+194,444
New +$2.23M 0.02% 664
2019
Q4 		– Sell
-42,141
Closed -$725K – 2097
2019
Q3 		$725K Buy
+42,141
New +$885K 0.01% 1015
2018
Q4 		– Sell
-58,749
Closed -$1.11M – 1831
2018
Q3 		$1.11M Buy
+58,749
New +$1.13M 0.01% 789

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace's VYGR Position: Q2 2026 in Review

Marshall Wace opened a new position in Voyager Therapeutics (VYGR) in Q2 2026: 139,422 shares worth $488K. The stake represents ﹤0.01% of the portfolio and ranks #2537 among its holdings. This is a return to the name: Marshall Wace previously reported a position in VYGR as recently as Q1 2024.

Marshall Wace first reported a position in VYGR in Q3 2018 and has held it in 15 quarters since. The position peaked at $5.37M in Q2 2023. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Marshall Wace held 139,422 shares of Voyager Therapeutics worth $488K as of Q2 2026.
  • Voyager Therapeutics was a new Marshall Wace position in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2537 holding.
  • Marshall Wace first reported a position in Voyager Therapeutics in Q3 2018 and has held it in 15 quarters since.
  • Marshall Wace's Voyager Therapeutics position peaked at $5.37M in Q2 2023.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.